Key facts
- This page summarizes Adam C. Vandervoort's Form 4 filing for Teladoc Health, Inc. (TDOC).
- 16 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 03 Mar 2023, 15:17.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Options Exercise
Award
Options Exercise
Additional SEC filing notes
Footnote F1
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F2
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
Footnote F3
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Footnote F4
On March 1, 2022, the reporting person was granted 22,571 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Footnote F5
On March 2, 2020, the reporting person was granted 5,824 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
Footnote F6
On March 2, 2021, the reporting person earned 9,900 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
Footnote F7
On March 2, 2022, the reporting person earned 1,661 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.
Footnote F8
On March 2, 2021, the reporting person was granted 5,736 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
Footnote F9
On March 2, 2022, the reporting person earned 4,337 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
Footnote F10
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
Footnote F11
Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022.
Footnote F12
The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023.
Footnote F13
On March 2, 2023, the reporting person earned 1,457 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.